# H1N1 Influenza Vaccine Immunogenicity in HIV-1 Infected Patients

> **NCT01111162** · PHASE4 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 120 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** H1N1 vaccination

## Key facts

- **NCT ID:** NCT01111162
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-03
- **Final completion:** 2010-12
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2016-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01111162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01111162, "H1N1 Influenza Vaccine Immunogenicity in HIV-1 Infected Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01111162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*